Propranolol Side Effects
Propranolol causes several important side effects that require monitoring, with the most clinically significant being hypoglycemia (especially in infants during fasting), hypotension, bradycardia, bronchospasm, and sleep disturbances. 1, 2
Most Common and Clinically Important Side Effects
Cardiovascular Effects
- Hypotension: Occurs frequently, with up to 72% of adult burn patients experiencing at least one episode 3. In pediatric populations, symptomatic hypotension is less common (approximately 1.2% severe cases) 4
- Bradycardia: Can occur in 15% of adults 3, though symptomatic bradycardia is rare in children (approximately 1.2%) 4. Severe bradycardia requiring pacemaker treatment has been reported, particularly in patients with Wolff-Parkinson-White syndrome 2
- Congestive heart failure: Beta-blockade can precipitate cardiac failure, especially in patients with pre-existing heart disease 2
- Intensification of AV block and arterial insufficiency (Raynaud-type) 2
Metabolic Effects
- Hypoglycemia: This is the most serious concern, particularly in infants and children. Risk is highest during fasting (such as preparation for surgery), in preterm infants, those with low weight, faltering growth, or poor feeding 1, 2. Propranolol must be held during times of diminished oral intake or vomiting 1. Beta-blockade masks warning signs of hypoglycemia (tachycardia, tremor) making detection more difficult 2
Respiratory Effects
- Bronchospasm: Propranolol blocks bronchodilation and can provoke asthma attacks in susceptible patients 2. Approximately 1.8% of pediatric patients experience severe respiratory symptoms 4, with bronchial hyperreactivity reported in some cases 5
Neurological/Psychiatric Effects
- Sleep disturbances: Common enough to warrant dose reduction 1. Restless sleep reported in approximately 29% of cases 5
- Depression: Meta-analysis of antihypertensive trials demonstrates propranolol causes depression with statistically greater frequency than control medications 6
- Fatigue and lethargy: Dose-related, occurring in approximately 1.1% of hypertensive patients 7
- Mental depression manifested by insomnia, lassitude, weakness 2
- CNS effects: Visual disturbances, hallucinations, vivid dreams, disorientation, short-term memory loss 2
Gastrointestinal Effects
- Nausea, vomiting, epigastric distress, abdominal cramping, diarrhea, constipation (reported in approximately 11% of pediatric cases) 5
- Rare but serious: mesenteric arterial thrombosis, ischemic colitis 2
Dermatologic/Allergic Reactions
- Severe cutaneous reactions: Stevens-Johnson Syndrome, toxic epidermal necrolysis, exfoliative dermatitis, erythema multiforme, urticaria 2
- Anaphylactic/anaphylactoid reactions 2
- Psoriasiform rashes, alopecia 2
Other Effects
- Cold extremities: Reported in approximately 11% of pediatric cases 5
- Paleness and sweating: Common in infants 4
- Reduced feeding and agitation in infants 4
- Male impotence and Peyronie's disease 2
- Systemic lupus erythematosus 2
Critical Safety Considerations
Abrupt Discontinuation
Never stop propranolol abruptly in patients with coronary artery disease—this can cause exacerbation of angina or myocardial infarction 2. However, in infantile hemangioma treatment, abrupt cessation is considered safe 8.
Masking of Important Symptoms
- Masks signs of hyperthyroidism; abrupt withdrawal may precipitate thyroid storm 2
- Masks warning signs of hypoglycemia in diabetics 2
Dose-Related Patterns
Interestingly, serious side effects requiring intervention (hypoglycemia, hypotension, bronchial hyperreactivity) are not consistently dose-dependent 5, though fatigue and lethargy appear dose-related 2.
Population-Specific Risks
Infants and children are particularly susceptible to hypoglycemia due to effects on glycogenolysis and gluconeogenesis 1. Adults tolerate lower doses than children, with frequent hypotension even at modest dosing (0.61 mg/kg/day average) 3.
The overall incidence of adverse events in properly selected patients is relatively low (2.1-5.9% requiring treatment modification) 4, 7, but vigilance for serious complications remains essential.